Miragalin 50mg Capsule is a prescription-only medication containing pregabalin, a structurally novel gamma-aminobutyric acid (GABA) analog, used to treat a range of conditions including epilepsy, fibromyalgia, and neuropathic pain. The capsule is designed to provide a controlled release of the active ingredient over a prolonged period, allowing for effective management of symptoms. In epilepsy, Miragalin is indicated for the adjunctive treatment of partial seizures with or without secondary generalization. In fibromyalgia, it is used to treat the symptoms of this chronic condition, including chronic widespread pain. Additionally, Miragalin has been shown to be effective in the treatment of neuropathic pain, including peripheral and central neuropathic pain. The medication has a well-established safety profile and is generally well tolerated, with common side effects including dizziness, somnolence, and weight gain. Miragalin 50mg Capsule is available in a controlled-release formula, which allows for a consistent and predictable release of the active ingredient over a 24-hour period, providing improved efficacy and reduced peak-trough variability.